Technical Analysis for GLMD - Galmed Pharmaceuticals Ltd.

Grade Last Price % Change Price Change
C 0.40 10.68% 0.04
GLMD closed up 10.68 percent on Wednesday, April 24, 2024, on 21 percent of normal volume. It was able to find support at its 50 day moving average.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up

Date Alert Name Type % Chg
50 DMA Support Bullish 0.00%
Crossed Above 20 DMA Bullish 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Fell Below 20 DMA Bearish 10.68%
MACD Bearish Signal Line Cross Bearish 10.68%
50 DMA Support Bullish 10.68%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 10.68%
Narrow Range Bar Range Contraction 10.68%

   Recent Intraday Alerts

Alert Time
Up 5% about 4 hours ago
Reversed from Up about 7 hours ago
Gap Up Closed about 7 hours ago
Rose Above 20 DMA about 7 hours ago
20 DMA Support about 7 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

GalMed Medical Research Ltd. researches and develops proprietary drugs for the treatment of lipid metabolism related diseases. The company has developed a series of proprietary fatty acid bile-acid conjugates (FABACs) which selectively inhibit the enzyme Stearoyl-CoA Desaturase (SCD1), a key regulator in lipid metabolism. It's flagship clinical compound Aramchol (arachidyl amido cholanoic acid), has the potential to modify several of the key disorders related to lipid metabolism, including fatty liver, gallstones, diabetes, hyperlipidemia, cancer, and alzheimer's disease. The company is based in Tel Aviv, Israel. GalMed Medical Research Ltd. operates as a subsidiary of Galmed International Ltd.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Acid Diabetes Alzheimer's Disease Lipid Medical Research Metabolism Hepatology Fatty Acids Fatty Liver Hyperlipidemia

Is GLMD a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 7.764
52 Week Low 0.2601
Average Volume 247,181
200-Day Moving Average 0.55
50-Day Moving Average 0.36
20-Day Moving Average 0.37
10-Day Moving Average 0.38
Average True Range 0.03
RSI (14) 59.02
ADX 24.72
+DI 25.59
-DI 16.68
Chandelier Exit (Long, 3 ATRs) 0.34
Chandelier Exit (Short, 3 ATRs) 0.41
Upper Bollinger Bands 0.43
Lower Bollinger Band 0.30
Percent B (%b) 0.78
BandWidth 34.03
MACD Line 0.01
MACD Signal Line 0.01
MACD Histogram 0.0012
Fundamentals Value
Market Cap 1.6 Million
Num Shares 4.01 Million
EPS -3.02
Price-to-Earnings (P/E) Ratio -0.13
Price-to-Sales 0.00
Price-to-Book 0.09
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.47
Resistance 3 (R3) 0.46 0.43 0.46
Resistance 2 (R2) 0.43 0.41 0.43 0.45
Resistance 1 (R1) 0.41 0.40 0.42 0.42 0.45
Pivot Point 0.39 0.39 0.39 0.39 0.39
Support 1 (S1) 0.37 0.37 0.38 0.38 0.35
Support 2 (S2) 0.34 0.36 0.34 0.35
Support 3 (S3) 0.33 0.34 0.34
Support 4 (S4) 0.33